Loading resource…

Laura M. Jacobsen, MD; Desmond A. Schatz, MD
Type 1 diabetes is characterized by hyperglycemia resulting from the autoimmune destruction of insulin-producing beta cells in the pancreas. It accounts for a significant portion of diabetes cases globally and is associated with various complications, including microvascular and macrovascular diseases. The review discusses the presence of autoantibodies at diagnosis, the typical age of onset, and the necessity for lifelong insulin therapy, including modern management techniques such as continuous glucose monitoring and insulin pumps.
No account needed